Genelabs' CFO Quits; Aebersold Lands on Rosetta Biosoftware's SAB; Dolginow Leaves Gene Logic; Sequenom Hires Sales VP; and Others | GenomeWeb
NEW YORK (GenomeWeb News) – Genelabs Technologies this week said CFO Matthew Loar will resign on Sept. 1. The company said he has taken a job at an undisclosed biotech company.
James Smith, Genelabs’ president and CEO, will assume Loar’s duties until a permanent replacement is found.
In the same statement, Genelabs said it hired Peter Young to be its vice president of biology. Young comes to Genelabs from Celera Genomics, where he held the same position.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.